PEGylated Magnetic Liposomes

Catalog NumberBL-0000079
DescriptionPEG reserved irreplaceable advantages for liposome modification due to its low toxicity, non-antigenicity, good amphiphilicity and biocompatibility approved by the FDA. PEG modification consists of targeting properties that can prolong the half-life of magnetic liposomes, improve stability in circulation, and alter biological distributions of magnetic liposomes.
AppearanceTranslucent liquid; PEGylated magnetic liposomes are packaged in amber vials; No sedimentation in the bottom of the vial usually due to liposomes' small sizes.
Shelf LifeIt is recommended to use products within 4 months of manufacturing date.
StoragePEGylated Magnetic Liposomes should be kept in the dark and refrigerated at 4°C to avoid liposome hydrolysis and NEVER be frozen.
ShippingAll liposome-based formulations are shipped in insulated packaging on blue ice at 4°C using overnight shipping or international express shipping.
Liposome Concentration1,2-dipalmitoyl-sn-glycero-3-phosphocholine: Cholesterol: PEG(2000) : DMPE-DTPA-Gd (37:33:5:25) (molar ratio percentage)
Mean Particle Size100 nm
BufferDefaulted with phosphate-buffered saline; Other buffers or deionized water can be provided according to your needs.
NoteMagnetic liposomes should not be frozen; Ice crystals that form in lipid membranes can rupture membranes and change the size of liposomes, leading to encapsulated drug release and limiting overall effectiveness. Magnetic liposomes should always be stored in the dark at 4°C unless restored from room temperature for brief periods before animal dosing.

※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Related Products

Online Inquiry

Verification code

Copyright © BOC Sciences. All rights reserved.